A deal has been reached by OraSure Technologies and the Bill & Melinda Gates Foundation to provide 50 developing Asian and African countries access to OraSure's OraQuick HIV Self-Test at a reduced price. Under the agreement, OraSure will receive subsidies and reimbursements worth up to $20 million from the Gates Foundation over four years to maintain availability of the rapid, point-of-care test.
Gates Foundation, OraSure to bring HIV test to developing nations
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.